Molecular Pathology of Pancreatic Cancer.
Options
BORIS DOI
Publisher DOI
PubMed ID
35326675
Description
Pancreatic ductal adenocarcinoma (PDAC) is a biologically aggressive malignancy showing a remarkable resistance to existing therapies and is often diagnosed at an advanced stage, leaving only about 15-20% of patients with an option for surgical resection [...].
Date of Publication
2022-03-16
Publication Type
Article
Language(s)
en
Additional Credits
Series
Cancers
Publisher
MDPI AG
ISSN
2072-6694
Access(Rights)
open.access